Musk says next Neuralink brain implant expected in ‘next week or so’

Musk says next Neuralink brain implant expected in ‘next week or so’

Jonathan Raa | Nurphoto | Getty Images Elon Musk said Wednesday that his brain tech startup Neuralink hopes to implant its system in a second human patient within “the next week or so.” Executives also said the company is making changes to try and reduce the hardware problems it encountered with its first participant. Neuralink … Read more

FTC to sue PBMs over drug prices including insulin

FTC to sue PBMs over drug prices including insulin

FTC Chairwoman Lina Khan testifies during the House Appropriations Subcommittee on Financial Services and General Government hearing titled “Fiscal Year 2025 Request for the Federal Trade Commission,” in Rayburn Building on Wednesday, May 15, 2024. Tom Williams | CQ-Roll Call, Inc. | Getty Images The Federal Trade Commission is planning to sue three large U.S. … Read more

Samsung Galaxy Ring launch: Price, specs, feature, availability

Samsung Galaxy Ring launch: Price, specs, feature, availability

The Samsung Galaxy Ring has the ability to track various health metrics such as heart rate. It is Samsung’s first foray into the smart ring category of product as it hopes to keep users locked into its ecosystem of devices from smartwatches to smartphones. Arjun Kharpal | CNBC PARIS — Samsung launched the Galaxy Ring … Read more

Weight loss stocks should grab big gains, Tema ETFs’ CEO suggests

Weight loss stocks should grab big gains, Tema ETFs’ CEO suggests

Tema ETFs has been capitalizing on the risk appetite for weight loss stocks. It is behind the GLP-1, Obesity & Cardiometabolic ETF (HRTS), which is up 26% since its inception last November. The firm’s founder and CEO Maurits Pot thinks the winning weight loss trade isn’t based on just hype. “The companies we track and … Read more

Novo Nordisk weight loss drugs linked to rare eye condition: study

Novo Nordisk weight loss drugs linked to rare eye condition: study

A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023.  George Frey | Reuters Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye condition. Semaglutide, which is present in weight loss drugs including Novo Nordisk’s Ozempic … Read more

Brain implant Paradromics launches patient registry

Brain implant Paradromics launches patient registry

Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Aamir Ahmed Khan, PhD, Principal Electrical Engineer for Paradromics, works on the Transceiver which connects to the brain implants.  Austin based Paradromics is developing a brain-computer interface to aide disabled and non-verbal patients with communication.  Julia Robinson … Read more

Can’t understand your teenager’s behavior? Psychologists have tips to offer

Can’t understand your teenager’s behavior? Psychologists have tips to offer

Anxiety symptoms vary widely from moodiness to lashing out.  Carol Yepes | Moment | Getty Images Slamming doors, throwing tantrums, unexpected crying, and one-sided conversations at the dinner table. If these are common occurrences in your household, you are probably raising a teenager. Teenagers are often perceived as entitled brats with little or no control … Read more

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

FDA approval of Eli Lilly’s Alzheimer’s drug cements our decision not to take profits

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Rally in markets: Stocks were higher across the board Tuesday afternoon, led by the Nasdaq Composite , which added 0.7% and was on pace for back-to-back … Read more

FDA approves Eli Lilly Alzheimer’s drug donanemab

FDA approves Eli Lilly Alzheimer’s drug donanemab

A sign with the company logo sits outside of the headquarters campus of Eli Lilly and Company on March 17, 2024 in Indianapolis, Indiana. Scott Olson | Getty Images The Food and Drug Administration on Tuesday approved Eli Lilly‘s Alzheimer’s drug donanemab, expanding the limited treatment options for the mind-wasting disease in the U.S. The … Read more

Pfizer stock recovers after Covid decline but some employees struggle

Pfizer stock recovers after Covid decline but some employees struggle

Kena Betancur | Corbis News | Getty Images Pfizer had a “phenomenal” first quarter — and Wall Street took notice, CEO Albert Bourla told thousands of employees during a companywide town hall on May 2, according to a recording heard by CNBC.  A day earlier, the pharmaceutical giant’s stock had closed 6% higher after its … Read more